EUVIMEDScopri EUVIMED
Klinische Studie (Phase IV)Open access · CC BY-NC-ND 4.0

Magnetic resonance guided high intensity focused ultrasound ( MR ‐ HIFU ) effectively reduces fibroid‐related symptoms and improves quality of life—A prospective single‐centre 12‐month follow‐up study

Saara Otonkoski iD, Antti Viitala, Gaber Komar, Teija Sainio, Anna Yanovskiy, Roberto Blanco Sequieros, Antti Perheentupa iD, Kirsi Joronen iD

Acta Obstetricia et Gynecologica Scandinavica · 2025-06 · 104 (6) · 1172-1180

DOI: 10.1111/aogs.15086 ↗

At a glance

Klinische Studie (Phase IV) in Acta Obstetricia et Gynecologica Scandinavica, published online on 2025-04-29. Written by Saara Otonkoski and 7 co-authors. Institution: Department of Obstetrics and Gynaecology, Turku University Hospital, Turku, Finland. Major MEDLINE topics: High-Intensity Focused Ultrasound Ablation, Leiomyoma, Quality of Life, Uterine Neoplasms. Cited 8 times so far (Crossref); 26 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Finnish Government Research Funding.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Introduction

Uterine fibroids are the most common benign tumors among women, and it is estimated that approximately 70% of women have one or multiple fibroids by the age of menopause. About 30% of these women suffer from symptoms related to the fibroids. Magnetic resonance‐guided high‐intensity focused ultrasound (MR‐HIFU) is a novel, non‐invasive treatment method for symptomatic uterine fibroids. Material and Methods In this prospective, single‐centre follow‐up study, 175 women with symptomatic uterine fibroids were treated with MR‐HIFU. The effect of MR‐HIFU on fibroid symptoms and quality of life was evaluated using a uterine fibroid‐specific quality of life questionnaire (UFS‐QoL). The main outcome measure was the symptom severity score and quality of life (QoL) before the MR‐HIFU and 3 and 12 months after the treatment. This study was registered at clinicaltrials.gov (NCT03937401).

Results

The median symptom severity score decreased from 56 (IQR 44–69) at baseline to 28 (IQR 16–44) at 3 months ( p < 0.01) and 25 (IQR 16–38) at 12 months ( p < 0.01) after treatment. The QoL score increased from a median of 48 (IQR 33–66) at baseline to 73 (IQR 59–93) at 3 months ( p < 0.01) and 78 (IQR 66–90) at 12 months after treatment ( p < 0.01). The reintervention rate during the 12‐month follow‐up was 2%.

Conclusions

MR‐HIFU significantly reduces the severity of fibroid‐related symptoms in selected patients as early as 3 months after MR‐HIFU. The effect persists at 12 months. There is also a significant improvement in the quality of life 3 months after treatment, which further increases at 12 months.

Subjects

MeSH terms (MEDLINE)

High-Intensity Focused Ultrasound AblationLeiomyomaQuality of LifeUterine NeoplasmsAdultFemaleHumansMiddle AgedFollow-Up StudiesMagnetic Resonance ImagingProspective StudiesTreatment Outcome

Author keywords

MR‐HIFUfibroidquality of lifeuterine fibroid

Authors and institutions

  • Department of Obstetrics and Gynaecology, Turku University Hospital, Turku, Finland.
  • University of Turku, Turku, Finland.
  • Department of Radiology, Turku University Hospital, Turku, Finland.
  • Department of Medical Physics, Turku University Hospital, Turku, Finland.

ORCID profiles: Saara Otonkoski, Antti Perheentupa, Kirsi Joronen

Funding

  • Finnish Government Research Funding

Cite

APA

Otonkoski, S., Viitala, A., Komar, G., Sainio, T., Yanovskiy, A., Blanco Sequieros, R., Perheentupa, A., & Joronen, K. (2025). Magnetic resonance guided high intensity focused ultrasound ( MR ‐ HIFU ) effectively reduces fibroid‐related symptoms and improves quality of life—A prospective single‐centre 12‐month follow‐up study. Acta Obstetricia et Gynecologica Scandinavica, 104(6), 1172-1180. https://doi.org/10.1111/aogs.15086

Vancouver

Otonkoski S, Viitala A, Komar G, Sainio T, Yanovskiy A, Blanco Sequieros R, et al. Magnetic resonance guided high intensity focused ultrasound ( MR ‐ HIFU ) effectively reduces fibroid‐related symptoms and improves quality of life—A prospective single‐centre 12‐month follow‐up study. Acta Obstetricia et Gynecologica Scandinavica. 2025;104(6):1172-1180. doi:10.1111/aogs.15086

BibTeX
@article{Otonkoski2025,
  author = {Otonkoski, Saara and Viitala, Antti and Komar, Gaber and Sainio, Teija and Yanovskiy, Anna and Blanco Sequieros, Roberto and Perheentupa, Antti and Joronen, Kirsi},
  title = {Magnetic resonance guided high intensity focused ultrasound ( MR ‐ HIFU ) effectively reduces fibroid‐related symptoms and improves quality of life—A prospective single‐centre 12‐month follow‐up study},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2025},
  volume = {104},
  number = {6},
  pages = {1172--1180},
  doi = {10.1111/aogs.15086}
}
Start for free →